Phibro Animal Health (PAHC) Tops Q2 EPS by 4c, Reaffirms FY17 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Phibro Animal Health Corp. (PAHC) PT Raised to $34 at Piper Jaffray
February 8, 2017 9:17 AM ESTPiper Jaffray raised its price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $34.00 (from $32.00) while maintaining a Overweight rating. Phibro reported in-line revenues and upside to earnings for 2Q17, where revenues of $192M were only slightly below the Street's estimates of $193M, while... More
